We hypothesized that compensatory cross-regulation of ERK and AKT/mTOR signaling leads to sustained activity of critical downstream signaling targets such as RPS6, thereby allowing GBM cells to proliferate unabated and escape cell death. Here, AKT1 is linked to glioblastoma.